TABLE 1

Classification of Participants in Study

ParameterGroup 1: HIV+/IDU+Group 2: HIV−/IDU+Group 3 (Control): HIV−/IDU−
Number of patients (n)171329
Age (y)40.3 ± 5.932.8 ± 7.731.6 ± 8.9
Sex (M/F)13/410/316/13
  • Data are mean ± SD.